MoneyWorks4Me

Natco Pharma board to consider Interim Dividend

03 Feb 2014 Evaluate

Natco Pharma has informed that a meeting of the Board of Directors of the Company will be held on February 13, 2014, to consider the unaudited financial Results for the quarter ended December 31, 2013, to consider Interim Dividend, if any, for the financial year 2013-14 and related matters etc.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..